Tumor-associated Macrophages and Neuroendocrine Differentiation Decrease the Efficacy of Bevacizumab Plus Chemotherapy in Patients With Advanced Colorectal Cancer.
- Resource Type
- journal article
- Source
- Clinical Colorectal Cancer; Jun2019, Vol. 18 Issue 2, pe244-e250, 7p
- Subject
- Language
- ISSN
- 15330028